tiprankstipranks
CG Oncology, Inc. (CGON)
NASDAQ:CGON
US Market
CGON
CG Oncology, Inc.
RESEARCH TOOLSreports
Want to see CGON full AI Analyst Report?

CG Oncology, Inc. (CGON) Income Statement

303 Followers

CG Oncology, Inc. Income Statement

Last quarter (Q4 2025), CG Oncology, Inc.'s total revenue was $2.32M, an increase of 409.21% from the same quarter last year. In Q4, CG Oncology, Inc.'s net income was $-41.31M. See CG Oncology, Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 4.04M$ 1.14M$ 204.00K$ 191.00K$ 10.36M
Gross Profit
$ -607.00K$ 1.14M$ 204.00K$ 176.00K$ 10.35M
Operating Expenses
$ 190.17M$ 115.81M$ 55.65M$ 35.42M$ 22.95M
Depreciation and Amortization
$ 1.45M$ 32.00K$ 17.00K$ 15.00K$ 10.00K
EBITDA
$ -159.55M$ -114.63M$ -55.43M$ -35.23M$ -12.38M
Operating Income
$ -190.77M$ -114.67M$ -55.45M$ -35.25M$ -12.61M
Other Income/Expenses
$ 29.78M$ 26.63M$ 6.84M$ -197.00K$ -233.00K
Pretax Income
$ -161.00M$ -88.04M$ -48.61M$ -35.44M$ -12.84M
Net Income
$ -161.00M$ -88.04M$ -48.61M$ -35.44M$ -12.84M
Per Share Metrics
Basic EPS
$ -2.08$ -1.41$ -1.02$ -0.66$ -0.28
Diluted EPS
$ -2.08$ -1.41$ -1.02$ -0.66$ -0.28
Weighted Average Shares Outstanding
 77.30M 62.50M 66.64M 66.64M 66.64M
Weighted Average Shares Outstanding (Diluted)
 77.30M 62.50M 66.64M 66.64M 66.64M
Currency in USD

CG Oncology, Inc. Earnings and Revenue History